Brain Blogger Home
  • Home
  • About
    • Editor's Note
    • Contributors
  • Advertise
  • Archives
    • By Author
    • By Topic
    • By Year
    • By Month
  • Contact
  • Contribute
  • Topics
    • Popular
    • Series
    • Video
    • Carnivals
  • Sitemap
  • Subscribe
  • Neuroscience & Neurology
  • Psychology & Psychiatry
  • Health & Healthcare
  • More >>
    • BioPsychoSocial Health
    • Complementary & Alternative Medicine
    • Drugs & Clinical Trials
    • History of Medicine
    • Law & Politics
    • Living with a Brain Disorder
    • Opinion
    • Site News
    • Stigmatization
Brain Blogger RSS Feed

Brain Blogger Feed - 3500+ Readers

Follow BB:

Brain Blogger on FaceBook Brain Blogger on twitter Brain Blogger on Flickr Brain Blogger on YouTube
Psychology & Psychiatry
March 14, 2006

Schizophrenia Demystified

By Shaheen E Lakhan, MD, PhD, MEd, MS | 1 Comment | Share | Print | Email | Tweet | Like | 1+

Psychiatry_Psychology2.jpgAffecting nearly 1% of the population, schizophrenia is marked by chronic or reoccurring psychosis and behavioral-cognitive deficits. Dr. Kristin Cadenhead and Dr. David Granet of the UCSD School of Medicine discuss schizophrenia and delve into the nature of psychosis, early detection, and possible prevention.

Clinical symptoms of schizophrenia usually begin in late adolescence or early adulthood. They are generally grouped into three broad categories: “positive” or “negative” based on the pathological effects of normal functions, and “cognitive impairments.” Over time, positive and negative symptoms tend to be episodic and vary in intensity.

Positive symptoms include indications that are considered exaggerations or distortions of normal functions: psychosis, false beliefs (delusions; 90% incidence of all subjects), perception of something when indeed nothing exists in the perceptual field (hallucinations; 50% incidence), and bizarre behaviors (Hirsch & Weinburger, 2003).

Negative symptoms are deficit states in which fundamental emotions are either weakened or entirely deficient, including blunted affect, anhedonia (inability to experience pleasure from normal activities), apathy (loss of interest and motivation), social withdrawal, and alogia (diminished speech content). They have an earlier and more subtle onset, and are less episodic than psychotic symptoms.

Schizophrenia may encompass disturbances in cognition, usually related to attention and concentration, learning and memory, psychomotor speed (e.g. prolonged reaction time), and executive processing (e.g. formulating and initiating plans, abstract thinking, and problem-solving).

Schizophrenia is a devastating psychotic disorder for it destroys the social functioning and employability of patients, and the psychiatric community is increasingly recognizing such symptoms as the part of diagnosis and treatment. Generally, negative symptoms and cognitive impairment are the disabling mechanisms of schizophrenia. Patient may no longer have the ability to concentrate on and take pleasure in work, studies, and entertainment. Relatives and other observers may mistakenly identify the patient’s lack of will (avolition) and develop antagonistic thoughts towards the schizophrenic patient (e.g. thinking one is lazy or deliberately preventing an improved life) (Mueser & McGurk, 2004). Moreover, the patient’s lack of medical insight further hinders their ability to take advantage of effective coping strategies which may further agitate social withdrawal, depression, and risk of suicide.

References

Hirsch, S. R., & Weinburger, D. R. (2003). Schizophrenia (2nd ed.). Malden, MA: Blackwell Science.

Mueser, K. T., & McGurk, S. R. (2004). Schizophrenia. Lancet, 363(9426), 2063-207

Shaheen E Lakhan, MD, PhD, MEd, MS

Shaheen Lakhan, MD, PhD, MEd, MS, is executive director of the Global Neuroscience Initiative Foundation (GNIF). He is a published scholar in protein biomarkers, bioethics, biotechnology, education technology, and neurology. He serves on the editorial board of several scholarly publications and has been honored by the U.S. President and Congress.

Related Articles

  • Integration of the Biopsychosocial Model in Contemporary Psychiatry
  • Vulnerability-Stress-Coping Model for Schizophrenia
  • Integrating Schizophrenia Management
  • Psychiatry – Label-Based Quackery or Research-Based Science?
  • Preventing Schizophrenia, Part 1 – Overview
  • Why Do Schizophrenics Smoke Cigarettes?
  • Post-Partum Psychosis – Rare but Real

1 Response

    1. The Many Facets of Addiction | Brain Blogger says:
      April 29, 2012 at 9:12 pm

      [...] day.”– Large doses of methamphetamine can trigger psychotic episodes indistinguishable from schizophrenia. Vigabatrin, a drug for the treatment of epilepsy, may turn out to be the first government-approved [...]

      Reply

    Leave a Reply

    Click here to cancel reply.

    Subscribe without commenting


    Popular Posts

    • Mind Games - Science's Attempts at Thought Control
    • The Science of Stuttering
    • Risks of Personalized Medicine
    • Intelligence - Are You Holding Back Your Brain?
    • Is Grief a Mental Illness?
    • The Brain's Buying Power
    • The Cost of a Good Night's Sleep
    • Inside Your Brain on Holiday
    • Risk Factors for Recurrence of Depression
    • Salvia Divinorum - DEA Control over Magic in the Mint

    Future Posts

      Latest Posts

      • A Gateway to Weight Loss?
      • Intelligence – Do You Need it to be Successful?
      • A Trip for Terminal Patients
      • Memory Ain’t What It Used to Be – And That’s Good for Psychotherapy
      • The Science of Stuttering
      • Are Your Friends Making You Fat?
      • Beer – The Smarter Drink
      • Macroeconomics and Suicide
      • From Nymphomania to Hypersexuality
      • Commitment – It’s the new Love

      Comments

      • : I have used heroin for 20 year
      • Lino Baine: I am not aware that people wit
      • Lulu Jones: Hmm....this is interesting. I
      • Robert A. Yourell, MA: Hi Stephanie...OR they tried a
      • Stephnie: Based on the facts in the arti
      • Sammy: I was a test subject for one o
      • Veronica Pamoukaghlian, MA: Thank you for your insightful
      • Richard Kensinger, MSW: I agree w/ Howard Gardner's pe
      • Melbzi: Muso's and smoked pot.I q
      • Melbzi: I am 36 and from Melbourne Aus
      • CODER: When we get sick, really sick
      • Rusti Hauge: I don't see any evidence to th
      Sponsored Links

      SEO Company, IT Support, Free Cams, addicted, SEO, Designer Wholesale Sources, GNLD, chinese wholesale, memory improvement, Autism News Blog, Neurotherapist, HGH,  Banner Stands ,   Buy Asacol ,   Inpatient Treatment Centers in Florida ,   natural male enhancement pills ,   bankers conseco life insurance company

      Copyright © 2005-2012 Brain Blogger sponsored by Global Neuroscience Initiative Foundation (GNIF). All Rights Reserved.
      Disclaimer | Privacy Policy | Feed | Log in | ISSN 1931-6224 | 0.514s
      9rules Network Member